Parenteral pharmaceutical formulation in suspension, having sustained release, in low and ultralow dosage, in hormonal therapy in the climacteric syndrome

Details for Australian Patent Application No. 2010330982 (hide)

Owner Techsphere, S.A. de C.V.

Inventors Angeles Uribe, Juan; Savoir Vilboeuf, John Claude

Agent Griffith Hack

Pub. Number AU-A-2010330982

PCT Pub. Number WO2011/074931

Priority MX/a/2009/013768 15.12.09 MX

Filing date 14 December 2010

Wipo publication date 23 June 2011

International Classifications

A61K 31/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 9/16 Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/57 - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61P 5/30 Drugs for disorders of the endocrine system

A61P 5/34 Drugs for disorders of the endocrine system

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/074931 Priority application(s): WO2011/074931

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010331055-Fireproof door and fireproof door frame

2010330967-Apparatus and method of avoiding control channel blocking